Applications of toxicogenomics in safety evaluation and risk assessment
I tiakina i:
Kaituhi rangatōpū: | |
---|---|
Ētahi atu kaituhi: | , |
Hōputu: | Tāhiko īPukapuka |
Reo: | Ingarihi |
I whakaputaina: |
Hoboken, N.J. :
John Wiley & Sons,
c2011.
|
Ngā marau: | |
Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Rārangi ihirangi:
- Toxicology, "omics" technologies, and toxicogenomics : a primer
- Introduction to human health risk assessment
- Practical considerations for the application of toxicogenomics to risk assessment--early experience, current drivers, and a path forward
- Approaches and practical considerations for the analysis of toxicogenomics data
- Genomics in identifying mutagenic mode of action in carcinogenesis
- Application of genomics for predicting and understanding the mode of action for non-genotoxic carcinogens
- Genomics in characterizing endocrine toxicity
- Studying organ specific toxicity using gene expression profiling
- Toxicogenomic studies in human populations
- Toxicogenomics applied to ecological risk assessment
- Analysis of transcriptomic dose response data for toxicology and risk assessment
- Toxicogenomics as a tool for validating animal to human extrapolations in chemical risk assessment: concepts, applications and challenges
- Toxicogenomics and animal alternatives
- Toxicogenomics and the regulatory framework
- Standardization of gene expression information for the safety evaluation--activities in Japan -
- Applying transcriptional profiling in drug safety evaluation
- Reframing the risk assessment paradigm : towards a systems biology approach.